Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
Public ClinicalTrials.gov record NCT05393284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05393284
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Valo Health, Inc.
- Industry
- Enrollment
- 114 participants
Conditions and interventions
Interventions
- OPL-0401 Dose 1 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2022
- Primary completion
- Jul 31, 2024
- Completion
- Jul 31, 2024
- Last update posted
- Jun 16, 2024
2022 – 2024
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern California Retina Vitreous Associates | Mountain View | California | 94040 | — |
| Retina Consultants of Southern California | Riverside | California | 92503 | — |
| Southern California Permanente Medical Group | Riverside | California | 92505 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| California Retina Consultants | Santa Barbara | California | 93036 | — |
| Panorama Eye Care, LLC | Fort Collins | Colorado | 80528 | — |
| Mid Florida Eye Center | Mt. Dora | Florida | 32757 | — |
| Eye Associates of Northeast Louisiana | West Monroe | Louisiana | 71291 | — |
| The Retina Care Center | Baltimore | Maryland | 21209 | — |
| Massachussetts Eye and Ear | Boston | Massachusetts | 02114 | — |
| Retina Associates of Michigan | Grand Blanc | Michigan | 48439 | — |
| Vision Research Center Eye Associates of New Mexico | Albuquerque | New Mexico | 87102-3657 | — |
| North Carolina Retina Associates | Wake Forest | North Carolina | 27587 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29456 | — |
| Austin Retina Associates | Austin | Texas | 78705 | — |
| Austin Clinical Research, LLC | Austin | Texas | 78750 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Valley Retina Institute, PA | McAllen | Texas | 78503 | — |
| Austin Retina Associates - Round Rock | Round Rock | Texas | 78681 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
| Retina Consultants of Texas | The Woodlands | Texas | 77384 | — |
| Strategic Clinical Research Group LLC | Willow Park | Texas | 79606-1224 | — |
| Retina Associates of Utah | Salt Lake City | Utah | 84107 | — |
| Pacific Northwest Retina | Seattle | Washington | 98104 | — |
| Spokane Eye Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05393284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2024 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05393284 live on ClinicalTrials.gov.